These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6629596)

  • 1. Remission of rheumatoid arthritis and other disorders of immunity in patients taking monoamine oxidase inhibitors.
    Lieb J
    Int J Immunopharmacol; 1983; 5(4):353-7. PubMed ID: 6629596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase inhibitors in anxiety disorders.
    Tyrer P; Shawcross C
    J Psychiatr Res; 1988; 22 Suppl 1():87-98. PubMed ID: 3050061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoglycemic action of monoamineoxidase inhibitors (MAOI'S).
    Adnitt PI
    Diabetes; 1968 Oct; 17(10):628-33. PubMed ID: 5681080
    [No Abstract]   [Full Text] [Related]  

  • 4. [Indications for therapy using MAO inhibitors].
    Schmauss M; Erfurth A
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():2-6. PubMed ID: 2685853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of hydrazine group in hypoglycemia associated with the use of certain monoamine-oxidase inhibitors (MAOI's).
    Potter WZ; Zaharko DS; Beck LV
    Diabetes; 1969 Aug; 18(8):538-41. PubMed ID: 5808748
    [No Abstract]   [Full Text] [Related]  

  • 6. Limitation and potential hazards of MAOI's for the treatment of depressive symptoms in abstinent alcoholics.
    Schottenfeld RS; O'Malley SS; Smith L; Rounsaville BJ; Jaffe JH
    Am J Drug Alcohol Abuse; 1989; 15(3):339-44. PubMed ID: 2669469
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet monoamine oxidase inhibition as a potential indicator of favorable response to MAOI's in geriatric depressions.
    Georgotas A; Mann J; Friedman E
    Biol Psychiatry; 1981 Oct; 16(10):997-1001. PubMed ID: 7306621
    [No Abstract]   [Full Text] [Related]  

  • 8. Discrimination of the amphetamine cue. Effects of A, B and mixed type inhibitors of monoamine oxidase.
    Porsolt RD; Pawelec C; Roux S; Jalfre M
    Neuropharmacology; 1984 May; 23(5):569-73. PubMed ID: 6429563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biochemistry of depression and antidepressants].
    Strolin Benedetti M
    Encephale; 1982; 8(5):545-85. PubMed ID: 6189704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of monoamine oxidase inhibitors.
    McDaniel KD
    Clin Neuropharmacol; 1986; 9(3):207-34. PubMed ID: 3521845
    [No Abstract]   [Full Text] [Related]  

  • 11. [Monoamine oxidase inhibitors and food precautions. A comparison of utilization in Belgian psychiatric education institutes and current findings in the literature].
    Mallet L; Schittecatte M
    Acta Psychiatr Belg; 1996; 96(2):74-100. PubMed ID: 8693949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase inhibitors in rheumatoid arthritis-anti-tumor necrosis factor?
    Altschuler EL
    Int J Immunopharmacol; 2000 Nov; 22(11):1007-8. PubMed ID: 11203461
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug combinations in the treatment of refractory depression: a review.
    Stern SL; Mendels J
    J Clin Psychiatry; 1981 Oct; 42(10):368-73. PubMed ID: 6116699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A neuroscientific update on monoamine oxidase and its inhibitors.
    Schwartz TL
    CNS Spectr; 2013 Dec; 18 Suppl 1():25-32; quiz 33. PubMed ID: 24252505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The new generation of selective monoamine oxidase-inhibitors: biochemical, pharmacological and clinical perspectives.
    Riederer P; Laux G; Beckmann H; Saletu B; Waldmeier P; Fritze J; DaPrada M; Möller HJ; Schmauss M; Przuntek H
    Pharmacopsychiatry; 1988 Nov; 21(6):283-4. PubMed ID: 3244753
    [No Abstract]   [Full Text] [Related]  

  • 16. Protection of patients on MAOI's against hypertensive crises.
    Kline NS; Cooper TB; Suckow RF; Hallstrom C; Brebbia DR
    J Clin Psychopharmacol; 1981 Nov; 1(6):410-1. PubMed ID: 7334156
    [No Abstract]   [Full Text] [Related]  

  • 17. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
    Nolen WA
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical overview of monoamine oxidase inhibitors.
    Zisook S
    Psychosomatics; 1985 Mar; 26(3):240-6, 251. PubMed ID: 3887453
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of the STAR*D study: implications for clinicians and drug developers.
    Preskorn SH
    J Psychiatr Pract; 2009 Jan; 15(1):45-9. PubMed ID: 19182564
    [No Abstract]   [Full Text] [Related]  

  • 20. [New selective monoamine oxidase inhibitors in the treatment of depressive disorders].
    Psychiatr Prax; 1989 Aug; 16 Suppl 1():1-50. PubMed ID: 2587672
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.